Characterization of the Rubella Virus Nonstructural Protease Domain and Its Cleavage Site
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Guide for Common Viral Diseases of Animals in Louisiana
Sampling and Testing Guide for Common Viral Diseases of Animals in Louisiana Please click on the species of interest: Cattle Deer and Small Ruminants The Louisiana Animal Swine Disease Diagnostic Horses Laboratory Dogs A service unit of the LSU School of Veterinary Medicine Adapted from Murphy, F.A., et al, Veterinary Virology, 3rd ed. Cats Academic Press, 1999. Compiled by Rob Poston Multi-species: Rabiesvirus DCN LADDL Guide for Common Viral Diseases v. B2 1 Cattle Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 2 Deer and Small Ruminants Please click on the principle system involvement Generalized viral disease Respiratory viral disease Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 3 Swine Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 4 Horses Please click on the principle system involvement Generalized viral diseases Neurological viral diseases Respiratory viral diseases Enteric viral diseases Abortifacient/neonatal viral diseases Viral infections affecting the skin Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. B2 5 Dogs Please click on the principle system involvement Generalized viral diseases Respiratory viral diseases Enteric viral diseases Reproductive/neonatal viral diseases Back to the Beginning DCN LADDL Guide for Common Viral Diseases v. -
Comparative Analysis, Distribution, and Characterization of Microsatellites in Orf Virus Genome
www.nature.com/scientificreports OPEN Comparative analysis, distribution, and characterization of microsatellites in Orf virus genome Basanta Pravas Sahu1, Prativa Majee 1, Ravi Raj Singh1, Anjan Sahoo2 & Debasis Nayak 1* Genome-wide in-silico identifcation of microsatellites or simple sequence repeats (SSRs) in the Orf virus (ORFV), the causative agent of contagious ecthyma has been carried out to investigate the type, distribution and its potential role in the genome evolution. We have investigated eleven ORFV strains, which resulted in the presence of 1,036–1,181 microsatellites per strain. The further screening revealed the presence of 83–107 compound SSRs (cSSRs) per genome. Our analysis indicates the dinucleotide (76.9%) repeats to be the most abundant, followed by trinucleotide (17.7%), mononucleotide (4.9%), tetranucleotide (0.4%) and hexanucleotide (0.2%) repeats. The Relative Abundance (RA) and Relative Density (RD) of these SSRs varied between 7.6–8.4 and 53.0–59.5 bp/ kb, respectively. While in the case of cSSRs, the RA and RD ranged from 0.6–0.8 and 12.1–17.0 bp/kb, respectively. Regression analysis of all parameters like the incident of SSRs, RA, and RD signifcantly correlated with the GC content. But in a case of genome size, except incident SSRs, all other parameters were non-signifcantly correlated. Nearly all cSSRs were composed of two microsatellites, which showed no biasedness to a particular motif. Motif duplication pattern, such as, (C)-x-(C), (TG)- x-(TG), (AT)-x-(AT), (TC)- x-(TC) and self-complementary motifs, such as (GC)-x-(CG), (TC)-x-(AG), (GT)-x-(CA) and (TC)-x-(AG) were observed in the cSSRs. -
Validation of the Easyscreen Flavivirus Dengue Alphavirus Detection Kit
RESEARCH ARTICLE Validation of the easyscreen flavivirus dengue alphavirus detection kit based on 3base amplification technology and its application to the 2016/17 Vanuatu dengue outbreak 1 1 1 2 2 Crystal Garae , Kalkoa Kalo , George Junior Pakoa , Rohan Baker , Phill IsaacsID , 2 Douglas Spencer MillarID * a1111111111 1 Vila Central Hospital, Port Vila, Vanuatu, 2 Genetic Signatures, Sydney, Australia a1111111111 a1111111111 * [email protected] a1111111111 a1111111111 Abstract Background OPEN ACCESS The family flaviviridae and alphaviridae contain a diverse group of pathogens that cause sig- Citation: Garae C, Kalo K, Pakoa GJ, Baker R, nificant morbidity and mortality worldwide. Diagnosis of the virus responsible for disease is Isaacs P, Millar DS (2020) Validation of the easyscreen flavivirus dengue alphavirus detection essential to ensure patients receive appropriate clinical management. Very few real-time kit based on 3base amplification technology and its RT-PCR based assays are able to detect the presence of all members of these families application to the 2016/17 Vanuatu dengue using a single primer and probe set. We have developed a novel chemistry, 3base, which outbreak. PLoS ONE 15(1): e0227550. https://doi. org/10.1371/journal.pone.0227550 simplifies the viral nucleic acids allowing the design of RT-PCR assays capable of pan-fam- ily identification. Editor: Abdallah M. Samy, Faculty of Science, Ain Shams University (ASU), EGYPT Methodology/Principal finding Received: April 11, 2019 Synthetic constructs, viral nucleic acids, intact viral particles and characterised reference Accepted: December 16, 2019 materials were used to determine the specificity and sensitivity of the assays. Synthetic con- Published: January 17, 2020 structs demonstrated the sensitivities of the pan-flavivirus detection component were in the Copyright: © 2020 Garae et al. -
Measles and Rubella Initiative Outbreak Response Fund Application Standard Operating Procedures
M&RI SOP Feb 24, 2020 Final Measles and Rubella Initiative Outbreak Response Fund Application Standard Operating Procedures This update of the M&RI ORF Standard Operating Procedures (SOPs) includes the following modifications: 1. To encourage countries to submit applications for ORF support early in the evolution of the outbreak in order to effectively stop measles virus transmission before it becomes more widespread, M&RI will monitor indicators of timeliness of outbreak response immunization in accordance with Immunization Agenda 2030 guidelines; 2. To accelerate the process to receive support, M&RI has removed requirements for advance notification when requesting ORF support and has established a limited timeframe to evaluate the application for ORF support and to provide feedback or issue a decision letter; 3. To more comprehensively address outbreak response linked to timely and efficient use of vaccine, M&RI will allow for greater flexibility in areas of support on an exceptional basis and with adequate justification; 4. To reduce the likelihood of requested additional information or clarifications from M&RI, the SOPs provide greater detail regarding the key data elements and analysis recommended when investigating measles outbreaks and preparing reports, plans and budgets; 5. To maximize use of outbreak investigations and their follow up to strengthen immunization systems, M&RI requests countries to include findings from root cause analyses and, based on these, plans to improve routine immunization, surveillance and outbreak preparedness in the required post-outbreak report. A. Background The Measles and Rubella Initiative (M&RI) has provided funding through an outbreak response fund (ORF) since 2012 to support bundled vaccine and operational costs for measles and rubella outbreak response immunization (ORI), with Gavi supporting up to a total of US$10 million per year for Gavi-eligible countries. -
Bornavirus Immunopathogenesis in Rodents: Models for Human Neurological Diseases
Journal of NeuroVirology (1999) 5, 604 ± 612 ã 1999 Journal of NeuroVirology, Inc. http://www.jneurovirology.com Bornavirus immunopathogenesis in rodents: models for human neurological diseases Thomas Briese1, Mady Hornig1 and W Ian Lipkin*,1 1Laboratory for the Study of Emerging Diseases, Department of Neurology, 3101 Gillespie Neuroscience Research Facility, University of California, Irvine, California, CA 92697-4292, USA Although the question of human BDV infection remains to be resolved, burgeoning interest in this unique pathogen has provided tools for exploring the pharmacology and neurochemistry of neuropsychiatric disorders poten- tially linked to BDV infection. Two animal models have been established based on BDV infection of adult or neonatal Lewis rats. Analyis of these models is already yielding insights into mechanisms by which neurotropic agents and/or immune factors may impact developing or mature CNS circuitry to effect complex disturbances in movement and behavior. Keywords: Borna disease virus; neurotropism; humoral and cellular immune response; Th1 ±Th2 shift; apoptosis; dopamine; cytokines Introduction Borna disease virus (BDV), the prototype of a new disorders and schizophrenia (Amsterdam et al, family, Bornaviridae, within the nonsegmented 1985; Bode et al, 1988, 1992, 1993; Fu et al, 1993; negative-strand RNA viruses, infects the central Kishi et al, 1995; Waltrip II et al, 1995), others have nervous system (CNS) of warmblooded animals to not succeeded in replicating these ®ndings (Iwata et cause behavioral disturbances reminiscent of au- al, 1998; Kubo et al, 1997; Lieb et al, 1997; Richt et tism, schizophrenia, and mood disorders (Lipkin et al, 1997). Here we review two rodent models of al, 1995). -
Alphavirus Vectors for Therapy of Neurological Disorders Kenneth Lundstrom* Pantherapeutics, Rue Des Remparts 4, CH1095 Lutry, Switzerland
ell Res C ea m rc te h S & f o T h l Journal of Lundstrom, J Stem Cell Res Ther 2012, S4 e a r n a r p u DOI: 10.4172/2157-7633.S4-002 y o J ISSN: 2157-7633 Stem Cell Research & Therapy Review Article Open Access Alphavirus Vectors for Therapy of Neurological Disorders Kenneth Lundstrom* PanTherapeutics, Rue des Remparts 4, CH1095 Lutry, Switzerland Abstract Alphavirus vectors engineered for gene delivery and expression of heterologous proteins have been considered as valuable tools for research on neurological disorders. They possess a highly efficient susceptibility for neuronal cells and can provide extreme levels of heterologous gene expression. However, they generally generate short-term transient expression, which might limit their therapeutic use in many neurological disorders often requiring long-term even life-long presence of therapeutic agents. Recent development in gene silencing applying both RNA interference and microRNA approaches will certainly expand the application range. Moreover, alphaviruses provide interesting models for neurological diseases such as demyelinating and spinal motor diseases. Keywords: Alphaviruses; Gene delivery; Neuronal expression; Gene injections into the caudate nucleus showed strong neuronal expression silencing. throughout the 6 month study. No expression was observed in astrocytes and oligodendroglial cells. SV40-based delivery caused no Introduction evidence of inflammation or tissue damage. Both viral and non-viral vectors have provided interesting novel Despite these encouraging results obtained with both non-viral approaches in research on neurological disorders with a great potential and viral vectors described above alternative gene delivery methods for future therapeutic applications too [1,2]. -
Producing Vaccines Against Enveloped Viruses in Plants: Making the Impossible, Difficult
Review Producing Vaccines against Enveloped Viruses in Plants: Making the Impossible, Difficult Hadrien Peyret , John F. C. Steele † , Jae-Wan Jung, Eva C. Thuenemann , Yulia Meshcheriakova and George P. Lomonossoff * Department of Biochemistry and Metabolism, John Innes Centre, Norwich NR4 7UH, UK; [email protected] (H.P.); [email protected] (J.F.C.S.); [email protected] (J.-W.J.); [email protected] (E.C.T.); [email protected] (Y.M.) * Correspondence: [email protected] † Current address: Piramal Healthcare UK Ltd., Piramal Pharma Solutions, Northumberland NE61 3YA, UK. Abstract: The past 30 years have seen the growth of plant molecular farming as an approach to the production of recombinant proteins for pharmaceutical and biotechnological uses. Much of this effort has focused on producing vaccine candidates against viral diseases, including those caused by enveloped viruses. These represent a particular challenge given the difficulties associated with expressing and purifying membrane-bound proteins and achieving correct assembly. Despite this, there have been notable successes both from a biochemical and a clinical perspective, with a number of clinical trials showing great promise. This review will explore the history and current status of plant-produced vaccine candidates against enveloped viruses to date, with a particular focus on virus-like particles (VLPs), which mimic authentic virus structures but do not contain infectious genetic material. Citation: Peyret, H.; Steele, J.F.C.; Jung, J.-W.; Thuenemann, E.C.; Keywords: alphavirus; Bunyavirales; coronavirus; Flaviviridae; hepatitis B virus; human immunode- Meshcheriakova, Y.; Lomonossoff, ficiency virus; Influenza virus; newcastle disease virus; plant molecular farming; plant-produced G.P. -
Diagnosis and Treatment of Orf
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Diagnosis and treatment of orf Author : Graham Duncanson Categories : Farm animal, Vets Date : March 3, 2008 When I used to do a meat inspection for an hour each week, I came across a case of orf in one of the slaughtermen. The lesion was on the back of his hand. The GP thought it was an abscess and lanced the pustule. I was certain it was orf and got some pus into a viral transport medium. The Veterinary Investigation Centre in Norwich confirmed the case as orf and it took weeks to heal. I have always taken the zoonotic aspects of this disease very seriously ever since. When I got a pustule on my finger from my own sheep, I took potentiated sulphonamides by mouth and it healed within three weeks. I always advise clients to wear rubber gloves when dealing with the disease. I also advise any affected people to go to their GP, but not to let the doctor lance the lesion. Virus Orf, which should be called contagious pustular dermatitis, is not a pox virus but a Parapoxvirus. It is allied to viral diseases in cattle, pseudocowpox (caused by the most common virus found on the bovine udder) and bovine papular stomatitis (the oral form of pseudocowpox occurring in young cattle). Both these cattle viruses are self-limiting, rarely causing problems. Sheeppox, which is a Capripoxvirus, is not found in the UK or western Europe. However, it seems to have spread from the Middle East to Hungary. -
Orf, Also Known As Sheep Pox, Is a Common Disease
ORF http://www.aocd.org Orf, also known as sheep pox, is a common disease in sheep-farming regions of the world. Human infection with the orf virus is typically acquired by direct contact with open lesions of an infected animal. However, infection from fomites can also occur due to the virus being resistant to heat and dryness. An infected person will usually have a single nodular lesion at the point of contact, on the hand or forearm. The cause of orf is attributed to the orf virus. This virus is a member of the parapoxvirus genus which also contains milker’s nodule virus. The parapoxvirus genus is a member of the poxviridae family which also includes small pox and cowpox viruses. Orf is considered a zoonotic disease, meaning it affects animals; yet humans can contract the disease from infected sheep and goats. However, the orf virus is not transmitted human-to-human. Occupational acquisition of the disease is the most common means of contraction of the virus. Once a human is infected with the parapoxvirus a nodular lesion will appear. This lesion evolves through several stages. It begins as a papule but then progresses into a lesion with a red center surrounded by a white ring. The lesion then becomes red and weeping. If the lesion is located in an area with hair, temporary alopecia (hair loss) occurs. With further progression, the lesion becomes dry with black spots on the surface. It then flattens and forms a dry crust. The lesion then heals with minimal scarring. The progression of this disease occurs in about 6 weeks. -
Risk Groups: Viruses (C) 1988, American Biological Safety Association
Rev.: 1.0 Risk Groups: Viruses (c) 1988, American Biological Safety Association BL RG RG RG RG RG LCDC-96 Belgium-97 ID Name Viral group Comments BMBL-93 CDC NIH rDNA-97 EU-96 Australia-95 HP AP (Canada) Annex VIII Flaviviridae/ Flavivirus (Grp 2 Absettarov, TBE 4 4 4 implied 3 3 4 + B Arbovirus) Acute haemorrhagic taxonomy 2, Enterovirus 3 conjunctivitis virus Picornaviridae 2 + different 70 (AHC) Adenovirus 4 Adenoviridae 2 2 (incl animal) 2 2 + (human,all types) 5 Aino X-Arboviruses 6 Akabane X-Arboviruses 7 Alastrim Poxviridae Restricted 4 4, Foot-and- 8 Aphthovirus Picornaviridae 2 mouth disease + viruses 9 Araguari X-Arboviruses (feces of children 10 Astroviridae Astroviridae 2 2 + + and lambs) Avian leukosis virus 11 Viral vector/Animal retrovirus 1 3 (wild strain) + (ALV) 3, (Rous 12 Avian sarcoma virus Viral vector/Animal retrovirus 1 sarcoma virus, + RSV wild strain) 13 Baculovirus Viral vector/Animal virus 1 + Togaviridae/ Alphavirus (Grp 14 Barmah Forest 2 A Arbovirus) 15 Batama X-Arboviruses 16 Batken X-Arboviruses Togaviridae/ Alphavirus (Grp 17 Bebaru virus 2 2 2 2 + A Arbovirus) 18 Bhanja X-Arboviruses 19 Bimbo X-Arboviruses Blood-borne hepatitis 20 viruses not yet Unclassified viruses 2 implied 2 implied 3 (**)D 3 + identified 21 Bluetongue X-Arboviruses 22 Bobaya X-Arboviruses 23 Bobia X-Arboviruses Bovine 24 immunodeficiency Viral vector/Animal retrovirus 3 (wild strain) + virus (BIV) 3, Bovine Bovine leukemia 25 Viral vector/Animal retrovirus 1 lymphosarcoma + virus (BLV) virus wild strain Bovine papilloma Papovavirus/ -
The Togavirus RNA Replication Complex
The Togavirus RNA Replication Complex Pekka Kujala Institute of Biotechnology Department of Biosciences, Division of Biochemistry and Viikki Graduate School in Biosciences University of Helsinki, Finland ACADEMIC DISSERTATION To be presented, with the permission of the Faculty of Science of the University of Helsinki, for public criticism in the auditorium 1041 at Viikki Biocenter (Viikinkaari 5, Helsinki) on June 21st, 2000, at 12 o’clock noon. Helsinki 2000 Supervised by: Professor Leevi Kääriäinen Institute of Biotechnology University of Helsinki Reviewed by: Professor Carl-Henrik von Bonsdorff Department of Virology, Haartman Institute University of Helsinki and Docent Vesa Olkkonen Department of Biochemistry National Public Health Institute Helsinki Opponent: Docent Anu Jalanko Department of Human Molecular Genetics National Public Health Institute Helsinki ISBN 951-45-9443-6 Helsinki 2000 To the memory of my father THE TOGAVIRUS RNA REPLICATION COMPLEX ABBREVIATIONS ORIGINAL PUBLICATIONS ABSTRACT 1 INTRODUCTION 2 1. Togaviruses 2 1.1 Alphaviruses 2 1.1.1. Semliki Forest virus 3 1.1.2. SFV virion structure 4 1.2. Rubiviruses 4 1.2.1. Rubella virus 4 1.2.2. RUB virion structure 5 2. Replication cycle of togaviruses 5 2.1. The alphavirus replication cycle 7 2.1.1. Alphavirus entry 7 2.1.2. Alphavirus replication and translation of the nonstructural polyprotein 7 2.1.3. Translation of alphavirus structural proteins and virus maturation 8 2.1.4. SFV in cell culture 9 2.2. The rubella virus replication cycle 11 2.2.1. RUB entry and translation of the nonstructural polyprotein 11 2.2.2. Translation of RUB structural proteins and virus maturation 11 2.2.3. -
Rapid, Specific Detection of Alphaviruses from Tissue Cultures Using a Replicon-Defective Reporter Gene Assay
Rapid, Specific Detection of Alphaviruses from Tissue Cultures Using a Replicon-Defective Reporter Gene Assay Jiangjiao Li1., Wuyang Zhu1., Huanqin Wang1, Jiandong Li2, Quanfu Zhang2, Ying He1, Jia Li1, Juanjuan Fu1, Dexin Li2, Guodong Liang1* 1 Department of Viral Encephalitis, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (IVDC, China CDC), Beijing, China, 2 State Key Laboratory for Infectious Disease Prevention and Control (SKLID), Department of Viral Hemorrhagic Fever (IVDC, China CDC), Beijing, China Abstract We established a rapid, specific technique for detecting alphaviruses using a replicon-defective reporter gene assay derived from the Sindbis virus XJ-160. The pVaXJ expression vector containing the XJ-160 genome was engineered to form the expression vectors pVaXJ-EGFP expressing enhanced green fluorescence protein (EGFP) or pVaXJ-GLuc expressing Gaussia luciferase (GLuc). The replicon-defective reporter plasmids pVaXJ-EGFPDnsp4 and pVaXJ-GLucDnsp4 were constructed by deleting 1139 bp in the non-structural protein 4 (nsP4) gene. The deletion in the nsP4 gene prevented the defective replicons from replicating and expressing reporter genes in transfected BHK-21 cells. However, when these transfected cells were infected with an alphavirus, the non-structural proteins expressed by the alphavirus could act on the defective replicons in trans and induce the expression of the reporter genes. The replicon-defective plasmids were used to visualize the presence of alphavirus qualitatively or detect it quantitatively. Specificity tests showed that this assay could detect a variety of alphaviruses from tissue cultures, while other RNA viruses, such as Japanese encephalitis virus and Tahyna virus, gave negative results with this system.